Literature DB >> 306851

[High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].

H Sauer, W Wilmanns.   

Abstract

DNA metabolism in bone marrow cells was measured under high-dose Methotrexate/Leucovorin adjuvant chemotherapy of a patient with primary amputation of his right leg because of osteogenic sarcoma. The biochemical data showed that there was no rescue effect of Leucovorin after 200 mg/kg Methotrexate. Corresponding to this "biochemical failure" of the rescue effect the patient died from the complications of a long and very severe bone marrow suppression. To improve the safety of this therapeutic regimen the intravenous injection and in some cases a higher dose of Leucovorin is recommended.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306851     DOI: 10.1007/bf01000594

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  21 in total

Review 1.  Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor.

Authors:  R A Bender
Journal:  Cancer Treat Rev       Date:  1975-09       Impact factor: 12.111

2.  Multidrug chemotherapy in pulmonary treatment of osteosarcoma.

Authors:  W W Sutow; E A Gehan; T J Vietti; A E Frias; P G Dyment
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

3.  Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck.

Authors:  R A Lustig; P A DeMare; S Kramer
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

4.  [Chemotherapy of malignant bone tumors].

Authors:  K Höffken; S Seeber; W M Gallmeier; U Bruntsch; D K Hossfeld; C G Schmidt
Journal:  Chirurg       Date:  1977-04       Impact factor: 0.955

5.  [Thymidine kinase in normal and leukemic myeloid cells].

Authors:  W Wilmanns
Journal:  Klin Wochenschr       Date:  1967-05-15

Review 6.  Methotrexate revisited.

Authors:  E Frei
Journal:  Med Pediatr Oncol       Date:  1976

7.  Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.

Authors:  G Rosen; M L Murphy; A G Huvos; M Gutierrez; R C Marcove
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

8.  [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].

Authors:  H Vahrson; K Gorges
Journal:  Med Klin       Date:  1976-10-08

9.  Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.

Authors:  N Jaffe; E Frei; D Traggis; H Watts
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

10.  [Suppression of cytostatic effect of amethopterin (methotrexate) with methyltetrahydrofolic acid].

Authors:  H Sauer; L Jaenicke
Journal:  Blut       Date:  1974-05
View more
  2 in total

1.  [Multidrug chemotherapy of osteogenic sarcoma (author's transl)].

Authors:  G Prindull
Journal:  Blut       Date:  1979-10

2.  Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.

Authors:  H Eichholtz; K R Trott
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.